Inventiva Sa - Adr Share Price Today
(NASDAQ: IVA)

Name: Inventiva Sa - Adr Share Price Today (NASDAQ: IVA) - Inventiva Sa - Adr Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Inventiva Sa - Adr share price is $2.76 & ₹240.03 as on 6 Mar 2025, 2.30 'hrs' IST

$2.76

▲

-0.06

(-2.13%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Inventiva Sa - Adr share price in Dollar and Rupees. Guide to invest in Inventiva Sa - Adr stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Inventiva Sa - Adr, along with analyst recommendations, forecasts, and comprehensive financials.

Inventiva Sa - Adr share price movements

Today's Low: $2.72
Today's High: $2.88
$2.76
1.62%
Downside
Day's Volatility :5.55%
Upside
4.0%
52 Weeks Low: $1.53
52 Weeks High: $4.50
$2.76
44.57%
Downside
52 Weeks Volatility :66.0%
Upside
38.67%

Inventiva Sa - Adr (IVA) Returns

Period	Inventiva Sa - Adr	Sector (Health Care)	Index (Russel 2000)
3 Months	6.79%	2.1%	0.0%
6 Months	25.89%	-4.1%	0.0%
1 Year	-22.21%	2.2%	0.0%
3 Years	-74.36%	11.8%	-11.6%

Inventiva Sa - Adr (IVA) Key Statistics

in dollars & INR

Previous Close	$2.82
Open	$2.875
Today's High	$2.875
Today's Low	$2.7153
Market Capitalization	$229.8M
Today's Volume	$146.0
52 Week High	$4.5
52 Week Low	$1.53
Revenue TTM	$19.3M
EBITDA	$-98.4M
Earnings Per Share (EPS)	$-2.14
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-1642.76%

How to invest in Inventiva Sa - Adr Stock (IVA) from India?

It is very easy for Indian residents to invest directly in Inventiva Sa - Adr from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Inventiva Sa - Adr stock in both Indian Rupees (INR) and US Dollars (USD). Search for Inventiva Sa - Adr or IVA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Inventiva Sa - Adr or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Inventiva Sa - Adr shares which would translate to 0.315 fractional shares of Inventiva Sa - Adr as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Inventiva Sa - Adr, in just a few clicks!

Returns in Inventiva Sa - Adr (IVA) for Indian investors in Rupees

The Inventiva Sa - Adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Inventiva Sa - Adr investment value today

Current value as on today

₹80,996

Returns

₹19,004

(-19%)

Returns from Inventiva Sa - Adr Stock

₹23,967 (-23.97%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Inventiva Sa - Adr (IVA)

-57%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Inventiva Sa - Adr Stock from India on INDmoney has decreased by -57% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Inventiva Sa - Adr

Yiheng Capital LLC
5.05%
NEA Management Company, LLC
2.79%
Bvf Inc
1.31%
UBS Group AG
1.16%
Commonwealth Equity Services Inc
0.08%

Analyst Recommendation on Inventiva Sa - Adr

Buy

92%Buy

7%Hold

0%Sell

Based on 13 Wall street analysts offering stock ratings for Inventiva Sa - Adr(by analysts ranked 0 to 5 stars)

Based on 13 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Inventiva Sa - Adr Stock (IVA)

What analysts predicted

Upside of 1071.5%

Target:

$32.33

Current:

$2.76

Insights on Inventiva Sa - Adr Stock (Ticker Symbol: IVA)

Price Movement
In the last 1 month, IVA stock has moved up by 11.2%
IVA vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 85.7%
IVA vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 122.8%
Price to Sales
ForIVA every $1 of sales, investors are willing to pay $7.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

IVA Inventiva Sa - Adr Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$3.6M	↓ 50.97%
Net Income	$-38.2M	↑ 95.12%
Net Profit Margin	-1.1K%	↓ 787.3%

	FY19	Y/Y Change
Revenue	$7.8M	↑ 118.89%
Net Income	$-33.6M	↓ 10.1%
Net Profit Margin	-431.85%	↑ 619.67%

	FY20	Y/Y Change
Revenue	$452.5K	↓ 94.68%
Net Income	$-38.5M	↑ 4.64%
Net Profit Margin	-8.5K%	↓ 8068.96%

	FY21	Y/Y Change
Revenue	$4.7M	↑ 1027.42%
Net Income	$-56.1M	↑ 56.96%
Net Profit Margin	-1.2K%	↑ 7317.31%

	FY22	Y/Y Change
Revenue	$12.9M	↑ 190.39%
Net Income	$-57.4M	↑ 9.34%
Net Profit Margin	-445.64%	↑ 737.86%

	FY23	Y/Y Change
Revenue	$19.1M	↑ 43.5%
Net Income	$-120.5M	↑ 103.46%
Net Profit Margin	-631.84%	↓ 186.2%

	Q2 FY23	Q/Q Change
Revenue	$6.6M	-
Net Income	$-55.3M	-
Net Profit Margin	-834.63%	-

	Q4 FY23	Q/Q Change
Revenue	$16.5M	↑ 149.79%
Net Income	$-55.2M	↓ 0.2%
Net Profit Margin	-333.46%	↑ 501.17%

	Q1 FY24	Q/Q Change
Revenue	$16.5M	↑ 0.0%
Net Income	$-55.2M	↑ 0.0%
Net Profit Margin	-333.46%	↑ 0.0%

	Q2 FY24	Q/Q Change
Revenue	$2.7M	↓ 83.47%
Net Income	$-49.0M	↓ 11.11%
Net Profit Margin	-1.8K%	↓ 1459.85%

	Q3 FY24	Q/Q Change
Revenue	$2.7M	↑ 0.0%
Net Income	$-49.0M	↑ 0.0%
Net Profit Margin	-1.8K%	↑ 0.0%

	FY18	Y/Y Change
Profit	$2.5M	↓ 57.8%

	FY19	Y/Y Change
Profit	$7.8M	↑ 213.81%

	FY20	Y/Y Change
Profit	$452.5K	↓ 94.68%

	FY21	Y/Y Change
Profit	$3.6M	↑ 754.03%

	FY22	Y/Y Change
Profit	$12.9M	↑ 283.35%

	FY23	Y/Y Change
Profit	$19.1M	↑ 43.69%

	Q2 FY23	Q/Q Change
Profit	$6.2M	-

	Q4 FY23	Q/Q Change
Profit	$16.0M	↑ 159.34%

	Q1 FY24	Q/Q Change
Profit	$16.0M	↑ 0.0%

	Q2 FY24	Q/Q Change
Profit	$2.7M	↓ 82.89%

	Q3 FY24	Q/Q Change
Profit	$2.7M	↑ 0.0%

	FY18	Y/Y Change
Operating Cash Flow	$-38.9M	↑ 101.19%
Investing Cash Flow	$-477.8K	↓ 106.81%
Financing Cash Flow	$36.7M	↓ 28.32%

	FY19	Y/Y Change
Operating Cash Flow	$-31.6M	↓ 16.96%
Investing Cash Flow	$-917.9K	↑ 96.67%
Financing Cash Flow	$9.3M	↓ 74.04%

	FY20	Y/Y Change
Operating Cash Flow	$-37.2M	↑ 7.7%
Investing Cash Flow	$-10.4M	↑ 935.96%
Financing Cash Flow	$135.8M	↑ 1232.94%

	FY21	Y/Y Change
Operating Cash Flow	$-53.8M	↑ 55.7%
Investing Cash Flow	$-2.0M	↓ 79.05%
Financing Cash Flow	$28.8M	↓ 77.21%

	Q3 FY22	Q/Q Change
Operating Cash Flow	$-22.6M	↓ 13.75%
Investing Cash Flow	$-3.9M	↑ 2773.88%
Financing Cash Flow	$-1.1M	↓ 107.72%

	Q4 FY22	Q/Q Change
Operating Cash Flow	$-19.8M	↓ 17.29%
Investing Cash Flow	$-4.1M	↑ 0.0%
Financing Cash Flow	$24.7M	↓ 2265.91%

	Q1 FY23	Q/Q Change
Operating Cash Flow	$-22.6M	↑ 20.9%
Investing Cash Flow	$-3.9M	↑ 0.0%
Financing Cash Flow	$-1.1M	↓ 104.62%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-45.2M	↑ 100.0%
Investing Cash Flow	$-3.9M	↑ 0.0%
Financing Cash Flow	$-2.2M	↑ 100.0%

Inventiva Sa - Adr Technicals Summary

Sell

Neutral

Buy

Inventiva Sa - Adr is currently in a neutral trading position according to technical analysis indicators.

Inventiva Sa - Adr (IVA) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Inventiva Sa - Adr	11.02%	25.89%	-22.21%	-74.36%	-79.86%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Inventiva Sa - Adr	NA	NA	NA	0.0	-16.43	-1.13	NA	-1.51
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Inventiva Sa - Adr	Buy	$229.8M	-79.86%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Inventiva Sa - Adr

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil for the treatment of patients with mucopolysaccharidoses type VI. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company was founded in 2011 and is headquartered in Daix, France.

Organization	Inventiva Sa - Adr
Employees	123
CEO	Dr. Pierre Broqua Ph.D.
Industry	Health Technology

Management People of Inventiva Sa - Adr

Name	Title
Mr. Frederic Cren	Co-Founder, CEO & Director
Dr. Pierre Broqua Ph.D.	Co-Founder, Chief Scientific Officer & Deputy CEO
Mr. Jean Volatier	Deputy GM & CFO
Ms. Alice Roudot-Ketelers Pharm.D.	Chief Operating Officer
Mr. Eric Duranson L.L.M.	General Counsel
Ms. Nathalie Harroy	Head of Human Resources
Dr. Kristina Meyer Ph.D.	Executive VP and Business Development & Alliance Management
Dr. Michael Cooreman	Chief Medical Officer
Ms. Pascaline Clerc Ph.D.	Executive Vice President of Strategy & Corporate Affairs

Important FAQs about investing in IVA Stock from India :

What is Inventiva Sa - Adr share price today?

Inventiva Sa - Adr share price today stands at $2.76, Open: $2.88 ; Previous Close: $2.82 ; High: $2.88 ; Low: $2.72 ; 52 Week High: $4.50 ; 52 Week Low: $1.53.

The stock opens at $2.88, after a previous close of $2.82. The stock reached a daily high of $2.88 and a low of $2.72, with a 52-week high of $4.50 and a 52-week low of $1.53.

Can Indians buy Inventiva Sa - Adr shares?

Yes, Indians can invest in the Inventiva Sa - Adr (IVA) from India.

With INDmoney, you can buy Inventiva Sa - Adr at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Inventiva Sa - Adr at zero transaction cost.

How can I buy Inventiva Sa - Adr shares from India?

It is very easy to buy Inventiva Sa - Adr from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Inventiva Sa - Adr (IVA) be purchased?

Yes, you can buy fractional shares of Inventiva Sa - Adr with INDmoney app.

What are the documents required to start investing in Inventiva Sa - Adr stocks?

To start investing in Inventiva Sa - Adr, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.